Hu Youjia, Wong F Susan, Wen Li
Section of Endocrinology & Metabolism, Yale University School of Medicine, New Haven, 06520, USA.
Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, CF14 4XN, UK.
Pharmacol Res. 2017 May;119:219-226. doi: 10.1016/j.phrs.2017.01.034. Epub 2017 Feb 7.
The gut microbiota interact with innate immune cells and play an important role in shaping the immune system. Many factors may influence the composition of the microbiota such as mode of birth, diet, infections and medication including antibiotics. In diseases with a multifactorial etiology, like type 1 diabetes, manipulation and alterations of the microbiota in animal models have been shown to influence the incidence and onset of disease. The microbiota are an important part of the internal environment and understanding how these bacteria interact with the innate immune cells to generate immune tolerance may open up opportunities for development of new therapeutic strategies. In this review, we discuss recent findings in relation to the microbiota, particularly in the context of type 1 diabetes.
肠道微生物群与先天性免疫细胞相互作用,在塑造免疫系统方面发挥重要作用。许多因素可能影响微生物群的组成,如出生方式、饮食、感染以及包括抗生素在内的药物。在具有多因素病因的疾病中,如1型糖尿病,动物模型中微生物群的操控和改变已被证明会影响疾病的发病率和发病情况。微生物群是内环境的重要组成部分,了解这些细菌如何与先天性免疫细胞相互作用以产生免疫耐受,可能为开发新的治疗策略带来机遇。在本综述中,我们讨论了与微生物群相关的最新研究发现,特别是在1型糖尿病的背景下。